Semafor
US · 4 mins ago
GLP-1 use reaches new high in US
The percentage of US citizens currently taking GLP-1 drugs such as Wegovy for weight loss has almost quadrupled to 11% from 3% in 2024.
Do you trust Semafor?
Sign in to rate
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!